2-Hydroxy Probenecid-d6

2-Hydroxy Probenecid-d6 is a deuterated version of the pharmaceutical drug Probenecid. It is commonly used in the treatment of gout and hyperuricemia by increasing the excretion of uric acid from the body. The compound works by inhibiting the reabsorption of uric acid in the kidneys, thereby increasing its elimination through urine. The deuterated form of 2-Hydroxy Probenecid-d6 is used in pharmaceutical research and development, specifically in the area of pharmacokinetics and pharmacodynamics. Deuterium is a stable isotope of hydrogen and its use in drug development can provide valuable information on the metabolism and elimination of drugs in the body. Deuterated compounds have been shown to have longer half-lives, improved bioavailability, and reduced toxicity compared to their non-deuterated counterparts. Chemically, 2-Hydroxy Probenecid-d6 has the same molecular formula as Probenecid, which is C13H12D6NO4S. The compound has a molecular weight of 345.46 g/mol and is soluble in water, ethanol, and acetone. It is a white crystalline powder and is stable under normal conditions. In conclusion, 2-Hydroxy Probenecid-d6 is a valuable tool in pharmaceutical research and development due to its deuterated form. It is commonly used in the treatment of gout and hyperuricemia by increasing the excretion of uric acid from the body, and is chemically stable and soluble in various solvents.